Liz Parrish and 2yr follow-up from telomerase gene therapy Liz Parrish, founder of BioViva Sciences discusses the objective improvements in her biomarkers after taking gene therapy for telomerase and follastatin. Read More Ed Park, MD 02/05/2018 No Comments
The 2013 Nobel Prize – “Vesicles and traffic” – explained I believe the Nobel Prize committee is really recognizing the sentiment that I ended the book with: “I believe that when we can understand the behavior of cells more like the behavior of social insects, then we will be even closer to wisdom.” Read More Ed Park, MD 10/08/2013 No Comments